Literature DB >> 17412602

Complement activation in experimental and human temporal lobe epilepsy.

E Aronica1, K Boer, E A van Vliet, S Redeker, J C Baayen, W G M Spliet, P C van Rijen, D Troost, F H Lopes da Silva, W J Wadman, J A Gorter.   

Abstract

We investigated the involvement of the complement cascade during epileptogenesis in a rat model of temporal lobe epilepsy (TLE), and in the chronic epileptic phase in both experimental as well as human TLE. Previous rat gene expression analysis using microarrays indicated prominent activation of the classical complement pathway which peaked at 1 week after SE in CA3 and entorhinal cortex. Increased expression of C1q, C3 and C4 was confirmed in CA3 tissue using quantitative PCR at 1 day, 1 week and 3-4 months after status epilepticus (SE). Upregulation of C1q and C3d protein expression was confirmed mainly to be present in microglia and in a few hippocampal neurons. In human TLE with hippocampal sclerosis, astroglial, microglial and neuronal (5/8 cases) expression of C1q, C3c and C3d was observed particularly within regions where neuronal cell loss occurs. The membrane attack protein complex (C5b-C9) was predominantly detected in activated microglial cells. The persistence of complement activation could contribute to a sustained inflammatory response and could destabilize neuronal networks involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412602     DOI: 10.1016/j.nbd.2007.01.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  66 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

Review 2.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 3.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 4.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

5.  Innate immunity and inflammation in temporal lobe epilepsy: new emphasis on the role of complement activation.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

6.  Engulfed by Glia: Glial Pruning in Development, Function, and Injury across Species.

Authors:  Stephan Raiders; Taeho Han; Nicole Scott-Hewitt; Sarah Kucenas; Deborah Lew; Mary A Logan; Aakanksha Singhvi
Journal:  J Neurosci       Date:  2021-01-19       Impact factor: 6.167

Review 7.  Epileptogenesis.

Authors:  Asla Pitkänen; Katarzyna Lukasiuk; F Edward Dudek; Kevin J Staley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

8.  A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.

Authors:  Silvia Balosso; Mattia Maroso; Manuel Sanchez-Alavez; Teresa Ravizza; Angelisa Frasca; Tamas Bartfai; Annamaria Vezzani
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

9.  Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures.

Authors:  Sarah Jamali; Annick Salzmann; Nader Perroud; Magali Ponsole-Lenfant; Jennifer Cillario; Patrice Roll; Nathalie Roeckel-Trevisiol; Ariel Crespel; Jorg Balzar; Kurt Schlachter; Ursula Gruber-Sedlmayr; Ekaterina Pataraia; Christoph Baumgartner; Alexander Zimprich; Fritz Zimprich; Alain Malafosse; Pierre Szepetowski
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

10.  Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.

Authors:  Stefano Sotgiu; Maria R Murrighile; Gabriela Constantin
Journal:  BMC Neurol       Date:  2010-09-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.